Get the Weekly Intelligence Brief — top committee picks every Sunday.
NASDAQ · STOCK

Lantheus Holdings

LNTH Healthcare Unknown Updated July 31, 2026
$99.55
52W $47.25 – $111.86
50/100
$6.49B
23.7
-0.06
AI Committee Verdict
Watch
Conviction: High · 83% agreement · 6 analysts
+0.8%
-14.6%
0.06:1
High

Is LNTH Bullish or Bearish?

Mixed. Innellis AI committee rates Lantheus Holdings (LNTH) Watch with a composite score of 50/100 , based on 6 analysts with 83% agreement. Last updated July 31, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +9.86 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -10.14 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee sees neither a compelling opportunity nor a clear risk at this stage. Conditions remain neutral — patience is warranted.

Bull & Bear Case

Bull Case
  • ROE of 24.3% shows genuine earnings power backing the valuation — Value
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Price-to-book of 4.0x prices in significant intangible value — Value
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of July 31, 2026
Overall Committee Score
50/100
Agreement
83%
Analysts
6
Conviction
High
Sector Rank
Top 86%
of 93 Healthcare peers
Value Analyst neutral
55 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 24.3% shows genuine earnings power backing the valuation
− Price-to-book of 4.0x prices in significant intangible value
Growth Analyst bearish
38 / 100 · Moderate confidence
Growth story is weak, decelerating, or inconsistent
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst neutral
48 / 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Macro Analyst neutral
58 / 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst neutral
58 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 51.4 to 50.1.

Analyst-level changes:
  • Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
  • Portfolio Manager: +2 bearish signal(s).

Comparing 2026-07-30 to 2026-07-31 (1 day apart).

Technical Analysis

RSI (14)
36.7
Neutral
MACD Histogram
-0.896
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Hh Hl
Support
$85.00
Resistance
$100.40
Bollinger %B
0.01
Inside Bands
Price vs Moving Averages
EMA 9
$102.68 Below
EMA 21
$103.87 Below
EMA 50
$101.43 Below
EMA 200
$86.08 Above

Fundamental Analysis

Valuation
58
Growth
51
Profitability
1
Financial Health
100
Cash Flow
37
Valuation
P/E Ratio 23.7×
P/B Ratio 5.32×
PEG Ratio 1.64
Dividend Yield 0.00%
52W High $111.86
52W Low $47.25
Quality & Growth
ROE 21.4%
ROA 10.5%
Gross Margin 60.5%
Operating Margin 18.8%
Revenue Growth YoY
Debt / Equity 0.52
AI Fundamental Assessment
P/E ratio of 23.7 (inexpensive relative to a 15-40x range); Price-to-book of 5.3x; PEG ratio of 1.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.2%; Return on assets of 0.1%; Net margin of 0.2%; Gross margin of 0.6%; Current ratio of 2.83 (healthy short-term liquidity); Debt-to-equity of 0.52; Free cash flow margin of 0.9% (thin cash generation); Free cash flow per share is positive (5.74); Most recent quarter beat estimates by 15.9%; 2 consecutive earnings beats; EPS growth decelerating (+31.5% -> -12.6% QoQ); Analyst estimates falling over recent quarters
Get the Full LNTH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore LNTH Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime